Are you searching for therapy options for your chronic stroke patients? Learn how the FDA-approved Vivistim® can help increase neuroplasticity for improved hand and arm function.
Watch our recorded webinar featuring Dr. Jenna Tosto, of Mount Sinai Health System, who will discuss how she is optimizing long-term improvements and the importance of an interdisciplinary approach to ensure continuous care in stroke recovery.
Topics of Discussion:
Don't miss this opportunity to discover how Vivistim Therapy™ can help make stroke rehabilitation more effective for your patients.
Please note, this webinar is for healthcare professionals only. For stroke survivor events, go to www.vivistim.com/events/.
Watch On-Demand Now
Guest Speaker:
The MicroTransponder® Vivistim® Paired VNS™ System is intended to be used to stimulate the vagus nerve during rehabilitation therapy in order to reduce upper extremity motor deficits and improve motor function in chronic ischemic stroke patients with moderate to severe arm impairment. Do not use if the patient has had a bilateral or left cervical vagotomy. Risks may include, but are not limited to pain after surgery, hoarseness, bruising, swelling, coughing and throat irritation. Infection leading to explant is a risk associated with any device. Individual results may vary.
©2024 MicroTransponder Inc. All rights reserved. Vivistim, Vivistim Therapy and Paired VNS are trademarks of MicroTransponder Inc.